Jane Street’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Jane Street’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-74,140	Closed	-$5.92K	–	10004
2023 Q1	$5.92K	Hold	74,140	–	–	﹤0.01%	8795
2022 Q4	$11.2K	Buy	+74,140	New	+$8.53K	﹤0.01%	8748

Jane Street's ORIAW Position: Q2 2023 in Review

Jane Street sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 74,140 shares — an estimated $5.92K sold.

Jane Street first reported a position in ORIAW in Q4 2022 and held it in 2 quarters. The position peaked at $11.2K in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Jane Street reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Jane Street sold 74,140 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $5.92K.
Jane Street first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2022 and held it in 2 quarters.
Jane Street's Orion Biotech Opportunities Corp. Warrant position peaked at $11.2K in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.